Hasil Pencarian - Mark Shilkrut
- Menampilkan 1 - 3 hasil dari 3
-
1
-
2
-
3
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials oleh Howard L. Kaufman, Robert H. I. Andtbacka, Frances A. Collichio, Michael Wolf, Zhongyun Zhao, Mark Shilkrut, Igor Puzanov, Merrick Ross
Diterbitkan 2017-09-01
Artikel